Contact

Rink Solstice Home About Services Safety & Risks Player Casebook Guides & Resources Contact Independent context for the hockey community Ibogaine for Hockey A careful look at a high-risk, unproven substance entering conversations about concussion symptoms, chronic pain, addiction, and mental health among hockey players. Safety before hype · Evidence over anecdote · Plain language A collision sport, difficult health questions, and a need for clear limits on what is known. The question behind the claim Ibogaine in sports: a controversial treatment Ibogaine is a naturally occurring psychoactive alkaloid derived from the root bark of the Tabernanthe iboga plant. It has drawn attention in addiction treatment, trauma discussions, and experimental research, but it is not an approved medicine in the United States. A general overview of the compound’s history and chemistry is available through Wikipedia’s ibogaine entry . For athletes and former athletes, the subject can sound urgent because it touches opioid addiction, chronic pain, brain injuries, and mental health at once. That overlap does not establish efficacy. It does mean hockey players and families deserve language that distinguishes hypotheses, early findings, anecdotal experience, and evidence-based treatment. Interest in hockey-specific ibogaine questions has grown alongside broader conversations about contact sports. Discussion across football and collision-sport recovery often raises parallel questions, but no published hockey-specific controlled trial establishes ibogaine as a treatment for concussion, traumatic brain injury, CTE, or addiction. Unproven Early research and personal accounts are not the same as established clinical efficacy for hockey players. High-risk Cardiac complications, drug interactions, and a narrow therapeutic window make safety central. Context matters Concussions, chronic pain, substance use disorder, and post-career transition each need careful assessment. The hockey context

Keep the conversation clear.